贵州三力制药股份有限公司 2025年第三季度报告

Core Viewpoint - Guizhou Sanli Pharmaceutical Co., Ltd. has released its third-quarter report for 2025, ensuring the accuracy and completeness of the financial information presented [2][8]. Financial Data Summary - The financial statements for the third quarter of 2025 have not been audited [3][5]. - The report includes major accounting data and financial indicators, although specific figures are not detailed in the provided text [3][4]. - The company has confirmed that there were no significant changes in the financial indicators compared to the previous period [4]. Shareholder Information - The report does not provide details on the number of shareholders or changes in major shareholders [4]. Meeting Details - The fourth board meeting of Guizhou Sanli was held on October 27, 2025, with all nine directors present, and the meeting was deemed legally valid [9][10]. - The board approved the third-quarter report through a voting process, with all votes in favor [10][11]. Supervisory Board Meeting - The supervisory board meeting also took place on October 27, 2025, with all three supervisors present, confirming the meeting's legality [14]. - The supervisory board approved the third-quarter report with unanimous support [16].